The Medicare program effectively reduced insulin costs, improved adherence, and increased plan enrollment, benefiting both patients and the federal government. The initiative involved major insulin ...

CMS’ Part D Senior Savings Model effectively increased insulin use while reducing out-of-pocket costs among Medicare beneficiaries, according to a RAND report published Sept. 22. The program also ...

The Medicare prescription drug plan redesign under the Inflation Reduction Act of 2022 aims to simplify the Part D benefit while capping out-of-pocket spending for Part D–covered drugs. Whether and ...

President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare beneficiaries. The order would implement a “most favored nation” policy, tying ...